Fundraising Fox
/Companies
Sign in

Jupiter Biomedical Research

Palm Beach Gardens, US · Founded 2016 · Florida corporation

Find your way into Jupiter Biomedical Research

Sign up to see every warm intro you have to Jupiter Biomedical Research

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Jupiter Biomedical Research team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Jupiter Biomedical Research is a drug development company with patents for two therapeutic candidates: JBR-102, an oral treatment for glioblastoma multiforme and other brain tumors, and JBR-201, an antiviral treatment for measles virus infections and related neurological diseases. The company is pursuing regulatory approval from Health Canada and the FDA for its lead cancer candidate while advancing preclinical development of its antiviral program.

BiotechHealthtechLongevityMedical Devices

Founders & leadership

RC
Robert C. HackneyExecutive
RP
Richard P. TamboneExecutive
FG
Frank GerardiExecutive
CH
Charles H. BurnsExecutive
JF
John FanarasNamed on SEC filing
WG
William G. TuckerNamed on SEC filing
VT
Vivian TuckerNamed on SEC filing
DT
Dr. Tucker

Board

TS
Tipton ShonkwilerBoard director
DV
David VaughanBoard director

Reported raises · per SEC filings

Form D private placements

$2.2M disclosed across 5 rounds · 2017–2026

▶$30KraisedSep 2026 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank GerardiExecutive Officer, Director
  • Richard P. TamboneExecutive Officer, Director
  • Robert C. HackneyExecutive Officer, Director
  • John FanarasExecutive Officer, Director
  • Tipton ShonkwilerDirector
  • David VaughanDirector
Offering amount
$1M
Amount sold
$30K
Minimum investment
$5K
First sale
Sep 2026
Incorporated
Corporation, Florida
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$500KraisedMay 2026 · 30 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tipton ShonkwilerDirector
  • David VaughanDirector
  • Robert C. HackneyExecutive Officer, Director
  • Frank GerardiExecutive Officer, Director
  • John FanarasExecutive Officer, Director
  • Richard P. TamboneExecutive Officer, Director
Offering amount
$500K
Amount sold
$500K
Minimum investment
$5K
First sale
Feb 2026
Incorporated
Corporation, Florida
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$500KraisedNov 2025 · 27 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John FanarasExecutive Officer, Director
  • Robert C. HackneyExecutive Officer, Director
  • Tipton ShonkwilerDirector
  • Richard P. TamboneExecutive Officer, Director
  • Frank GerardiExecutive Officer, Director
Offering amount
$500K
Amount sold
$500K
Minimum investment
$5K
First sale
Jun 2025
Incorporated
Corporation, Florida
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$625KraisedNov 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank GerardiExecutive Officer, Director, Promoter
  • William G. TuckerExecutive Officer, Director, Promoter
  • Richard P. TamboneExecutive Officer, Director, Promoter
  • Kingsley WardDirector
  • John FanarasDirector
  • Robert C. HackneyDirector
  • Charles H. BurnsExecutive Officer, Director, Promoter
Amount sold
$625K
Minimum investment
$25K
First sale
Oct 2020
Incorporated
Corporation, Florida, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedApr 2017 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank GerardiDirector
  • William G. TuckerExecutive Officer, Director, Promoter
  • Richard TamboneExecutive Officer, Director
  • Charles H. BurnsExecutive Officer, Director
  • Vivian TuckerExecutive Officer, Director, Promoter
Offering amount
$500K
Amount sold
$500K
Minimum investment
$50K
Proceeds to insiders
$100K
First sale
Jan 2017
Incorporated
Corporation, Florida, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Jupiter BioventuresJupiter is a biotech company that discovers and develops new medicines across multiple therapeutic areas. The company is led by a team of experienced scientists and executives with a track record of creating approved drugs and founding successful biotech companies.

Companies working in the same space as Jupiter Biomedical Research.

Frequently asked questions

What does Jupiter Biomedical Research do?
Jupiter Biomedical Research is a drug development company with patents for two therapeutic candidates: JBR-102, an oral treatment for glioblastoma multiforme and other brain tumors, and JBR-201, an antiviral treatment for measles virus infections and related neurological diseases. The company is pursuing regulatory approval from Health Canada and the FDA for its lead cancer candidate while advancing preclinical development of its antiviral program.
How much funding has Jupiter Biomedical Research raised?
Jupiter Biomedical Research has disclosed $2.2M raised across 5 rounds.
Where is Jupiter Biomedical Research headquartered?
Jupiter Biomedical Research is headquartered in Palm Beach Gardens, US.